Prof. Ken Hermann MD, MBA.
Chairman, Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.

Prof. Hermann is the Chair of the Department of Nuclear Medicine since 2016. His field of expertise is molecular imaging and Theranostics. He has conducted several courses and training sessions in radiotracer therapies. Prof. Hermann has published several articles and reviews on this subject. He served as the part-time/visiting faculty to David Geffen School of Medicine at UCLA, Los Angeles, USA. He has been the associated Editor to the JNM, BMC Cancer. He also serves as the invited consultant to Novartis, Bayer, and multiple scientific advisory boards. His lectures will be directed at radiotracer therapy:

  1. Going forward with Theranostics: More questions than answers?
  2. PRRT - where are we heading to.